Financial Statements

Haemonetics Corporation (HAE)

$56.24

+4.14 (+7.95%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 79161267290-
Net Income 79775546-
Stock Dividends --159-161-69290
Dividend Paid -----
Retained Earnings 15879161267290

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 306344332324-
Annual Depreciation -511013183324
Capital Expenditure -37-49-119-75-
Net PPE 218306344332324

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -211211211211
New Purchases -----
Intangible and Goodwill 211211211211466

Haemonetics Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Haemonetics Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.